VISTAGEN THERAPEUTICS INC
VTGN · NASDAQ
Updated at 2026-10-13 15:30:43
- Today's High
- $0.23
- Today’s Low
- $0.21
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $0.23
- Previous Close
- $0.22
- Volume
- 739.9K
- Market Cap
- $10.05M
- P/E Ratio
- --
- EPS
- $-1.67
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 343 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, UNITED STATES, 94080
- Country
- US
- Listing Date
- 2010-10-18
- Fiscal Year End
- March
- Shares Outstanding
- 41.03M
- CIK
- 0001411685
- Website
- www.vistagen.com
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing and commercializing several drugs with the potential to treat anxiety, depression, and other central nervous system (CNS) disorders. The company is headquartered in South San Francisco, California.
Financial Metrics
Revenue
2026-06-30
$1.47M
2026-03-31
$465K
2025-12-31
$303K
2025-09-30
$258K
Operating Expenses
2026-06-30
$14.62M
2026-03-31
$17.18M
2025-12-31
$19.66M
2025-09-30
$20.31M
Net Income
2026-06-30
-$13.03M
2026-03-31
-$16.27M
2025-12-31
-$18.89M
2025-09-30
-$19.41M
Net Profit Margin
2026-06-30
-882.79%
2026-03-31
-3.49K%
2025-12-31
-6.23K%
2025-09-30
-7.52K%
Earnings Per Share
2026-06-30
$-0.30
2026-03-31
$-0.37
2025-12-31
$-0.45
2025-09-30
$-0.54
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$12.83M
2026-03-31
-$16.52M
2025-12-31
-$18.71M
2025-09-30
-$19.23M
Effective Tax Rate
2026-06-30
--
2026-03-31
-0.04%
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $1.47M | $465K | $303K | $258K |
| Operating Expenses | $14.62M | $17.18M | $19.66M | $20.31M |
| Net Income | -$13.03M | -$16.27M | -$18.89M | -$19.41M |
| Net Profit Margin | -882.79% | -3.49K% | -6.23K% | -7.52K% |
| Earnings Per Share | $-0.30 | $-0.37 | $-0.45 | $-0.54 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$12.83M | -$16.52M | -$18.71M | -$19.23M |
| Effective Tax Rate | -- | -0.04% | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.